Evidence map›Paper›PMID 40377675›Full record

ReviewInnere Medizin (Heidelberg, Germany)2025

[Diagnostics and treatment of osteoporosis in 2025 : An update on current guidelines].

Philipp Klemm, Nils Schulz, Uwe Lange, Björn Bühring

Abstract readReviewEnglish Abstract
PubMed Publisher
In one paragraph

Review in Innere Medizin (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. [Adjunctive therapies in geriatric ankle fracture patients].Unfallchirurgie (Heidelberg, Germany) · 2026
    Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Philipp KlemmAbteilung für Rheumatologie, Klinische Immunologie, Osteologie und Physikalische Medizin, Campus Kerckhoff der Justus-Liebig-Universität Gießen, Kerckhoff-Klinik, Benekestraße 2-8, 61231, Bad Nauheim, Deutschland. philipp.klemm@med.uni-giessen.de.
Nils SchulzAbteilung für Rheumatologie, Klinische Immunologie, Osteologie und Physikalische Medizin, Campus Kerckhoff der Justus-Liebig-Universität Gießen, Kerckhoff-Klinik, Benekestraße 2-8, 61231, Bad Nauheim, Deutschland.
Uwe LangeAbteilung für Rheumatologie, Klinische Immunologie, Osteologie und Physikalische Medizin, Campus Kerckhoff der Justus-Liebig-Universität Gießen, Kerckhoff-Klinik, Benekestraße 2-8, 61231, Bad Nauheim, Deutschland.
Björn BühringBergisches Rheuma-Zentrum, Cellitinnen-Krankenhaus St. Josef, Wuppertal, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoporosis is a relevant public health issue characterized by reduced bone mass and impaired bone microarchitecture, leading to an increased fracture risk. Osteoporosis is diagnosed based on low bone mineral density (BMD), specific fragility fractures and/or an elevated fracture risk. The BMD is one of the most important risk factors for the increased fracture risk that defines osteoporosis, alongside age and sex. Accordingly, treatment strategies focus on reducing the fracture risk. Risk gradients and an algorithm for fracture risk assessment guide treatment decisions. A primary osteoanabolic treatment is recommended for individuals with a 3-year fracture risk of 10% or higher and antiresorptive treatment where the risk exceeds 3%. The high disease burden and gaps in care highlight the need for targeted interventions. The introduction of new guidelines in Germany and Austria provides clear and individualized recommendations for action for the diagnosis and treatment of osteoporosis.

Indexed as

OsteoporosisPractice Guidelines as TopicBone DensityBone Density Conservation AgentsFemaleGermanyHumansMaleOsteoporotic FracturesRisk AssessmentRisk FactorsBone Density Conservation AgentsAntiresorptive therapyFemoral neck fracturesOsteoanabolic therapyOsteoporosis/fracture riskVertebral fractures

Identifiers

PMID40377675

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.